ALFA Finder| Revenue growth | FY26 Net Sales grew 11.23% YoY to ₹502.55 Cr. |
|---|---|
| Margins | Higher raw material prices in Beverages; lower prices in OTC. |
| Demand visibility | Positive outlook with relaunch of Relief brand and new capacity. |
| Management confidence | Confident in demand environment and unique value propositions. |
Growth
FY26 Net Sales grew 11.23% to ₹502.55 Cr. FY26 PAT rose 13.95% to ₹57.92 Cr.
Outlook
New sanitary pad plant starting May 2026; target 100k chemists by Sept FY27; relaunching Relief brand.
Risks
COGS inflation due to Middle East wars affecting crude prices and supply chains; legal lease rent charge.
Earnings Call filed with BSE, NSE: AMRUTANJAN. Summary written with AI assistance from the document.
Amrutanjan Health Care Ltd: key numbers
- Share price
- ₹520.15
- Market cap
- ₹1,504 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 26.2×Sector 43.8×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 3.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrutanjan Health Care Ltd
All →Amrutanjan Health Care Investor Presentation: Key Takeaways
Q2 FY27 net sales ₹135.2 Cr (+14.9%), PAT ₹17.3 Cr (+23.8%). H1 PAT ₹21.7 Cr, down 2.8% on cost pressure.
Amrutanjan Health Care Dividend
Amrutanjan Health Care set November 7, 2026 as the record date for its first FY2026-27 interim dividend. The dividend amount per share is not stated.
Amrutanjan Health Care Q2 FY27 Results: Net Profit ₹17.3 Cr, Up 23.6% YoY
Amrutanjan Health Care Ltd reported revenue from operations of ₹135.2 Cr (+14.9% YoY) and net profit of ₹17.3 Cr (+23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹17.3 Cr · +23.6% YoY
Amrutanjan Health Care Board Meeting Date
Amrutanjan Health Care scheduled its board meeting for 3 Nov 2026 to consider Q2/H1 results and 1st interim dividend. No financial figures or dividend amount are stated in this advance intimation.
Amrutanjan Health Care Other Announcement
Amrutanjan Health Care received a voluntary CRISIL ESG rating of 'Adequate' (score 60). No capital or operational impact arises from this rating.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.